Mong-Liang Lu, MD
- 4Articles
- 17.8KReads
- 2000–2013Active
- 12Collaborators
- 64Citations
About
Mong-Liang Lu, MD, has published extensively on schizophrenia and schizoaffective disorders, focusing on metabolic effects and weight management in patients treated with clozapine. Research topics include the use of adjunctive metformin and fluvoxamine to address metabolic disturbances and weight gain, as well as sleep-related eating disorders induced by antipsychotic medications. Lu's work spans clinical pharmacology and the management of treatment-resistant schizophrenia.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
